113 related articles for article (PubMed ID: 12215430)
1. Analysis of the catalytic domain of phosphatidylinositol 4-kinase type II.
Barylko B; Wlodarski P; Binns DD; Gerber SH; Earnest S; Sudhof TC; Grichine N; Albanesi JP
J Biol Chem; 2002 Nov; 277(46):44366-75. PubMed ID: 12215430
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of a wortmannin-sensitive human phosphatidylinositol 4-kinase.
Meyers R; Cantley LC
J Biol Chem; 1997 Feb; 272(7):4384-90. PubMed ID: 9020160
[TBL] [Abstract][Full Text] [Related]
3. Mouse p170 is a novel phosphatidylinositol 3-kinase containing a C2 domain.
Virbasius JV; Guilherme A; Czech MP
J Biol Chem; 1996 Jun; 271(23):13304-7. PubMed ID: 8663140
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a soluble adrenal phosphatidylinositol 4-kinase reveals wortmannin sensitivity of type III phosphatidylinositol kinases.
Downing GJ; Kim S; Nakanishi S; Catt KJ; Balla T
Biochemistry; 1996 Mar; 35(11):3587-94. PubMed ID: 8639510
[TBL] [Abstract][Full Text] [Related]
5. Characterization of type II phosphatidylinositol 4-kinase isoforms reveals association of the enzymes with endosomal vesicular compartments.
Balla A; Tuymetova G; Barshishat M; Geiszt M; Balla T
J Biol Chem; 2002 May; 277(22):20041-50. PubMed ID: 11923287
[TBL] [Abstract][Full Text] [Related]
6. Cloning of a human type II phosphatidylinositol 4-kinase reveals a novel lipid kinase family.
Minogue S; Anderson JS; Waugh MG; dos Santos M; Corless S; Cramer R; Hsuan JJ
J Biol Chem; 2001 May; 276(20):16635-40. PubMed ID: 11279162
[TBL] [Abstract][Full Text] [Related]
7. Palmitoylation controls the catalytic activity and subcellular distribution of phosphatidylinositol 4-kinase II{alpha}.
Barylko B; Mao YS; Wlodarski P; Jung G; Binns DD; Sun HQ; Yin HL; Albanesi JP
J Biol Chem; 2009 Apr; 284(15):9994-10003. PubMed ID: 19211550
[TBL] [Abstract][Full Text] [Related]
8. Functional expression and characterisation of a new human phosphatidylinositol 4-kinase PI4K230.
Gehrmann T; Gülkan H; Suer S; Herberg FW; Balla A; Vereb G; Mayr GW; Heilmeyer LM
Biochim Biophys Acta; 1999 Mar; 1437(3):341-56. PubMed ID: 10101268
[TBL] [Abstract][Full Text] [Related]
9. Isolation and molecular cloning of wortmannin-sensitive bovine type III phosphatidylinositol 4-kinases.
Balla T; Downing GJ; Jaffe H; Kim S; Zólyomi A; Catt KJ
J Biol Chem; 1997 Jul; 272(29):18358-66. PubMed ID: 9218477
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of two Arabidopsis type III phosphatidylinositol 4-kinase isoforms. A regulatory role for the pleckstrin homology domain.
Stevenson-Paulik J; Love J; Boss WF
Plant Physiol; 2003 Jun; 132(2):1053-64. PubMed ID: 12805633
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of a 92 kDa soluble phosphatidylinositol 4-kinase.
Nakagawa T; Goto K; Kondo H
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):643-9. PubMed ID: 8973579
[TBL] [Abstract][Full Text] [Related]
12. Lipid kinase and protein kinase activities of G-protein-coupled phosphoinositide 3-kinase gamma: structure-activity analysis and interactions with wortmannin.
Stoyanova S; Bulgarelli-Leva G; Kirsch C; Hanck T; Klinger R; Wetzker R; Wymann MP
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):489-95. PubMed ID: 9182708
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-phosphate-interacting domains in PIKfyve. Binding specificity and role in PIKfyve. Endomenbrane localization.
Sbrissa D; Ikonomov OC; Shisheva A
J Biol Chem; 2002 Feb; 277(8):6073-9. PubMed ID: 11706043
[TBL] [Abstract][Full Text] [Related]
14. Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase.
Gao Z; Konrad RJ; Collins H; Matschinsky FM; Rothenberg PL; Wolf BA
Diabetes; 1996 Jul; 45(7):854-62. PubMed ID: 8666133
[TBL] [Abstract][Full Text] [Related]
15. Distinct Golgi populations of phosphatidylinositol 4-phosphate regulated by phosphatidylinositol 4-kinases.
Weixel KM; Blumental-Perry A; Watkins SC; Aridor M; Weisz OA
J Biol Chem; 2005 Mar; 280(11):10501-8. PubMed ID: 15634669
[TBL] [Abstract][Full Text] [Related]
16. Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin.
Domin J; Pages F; Volinia S; Rittenhouse SE; Zvelebil MJ; Stein RC; Waterfield MD
Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):139-47. PubMed ID: 9337861
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of a human phosphatidylinositol 4-kinase.
Wong K; Cantley LC
J Biol Chem; 1994 Nov; 269(46):28878-84. PubMed ID: 7961848
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological concentrations of amyloid beta proteins directly inhibit rat brain and recombinant human type II phosphatidylinositol 4-kinase activity.
Wu B; Kitagawa K; Zhang NY; Liu B; Inagaki C
J Neurochem; 2004 Dec; 91(5):1164-70. PubMed ID: 15569259
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the Rac1-specific exchange factor Tiam1 involves both phosphoinositide 3-kinase-dependent and -independent components.
Fleming IN; Gray A; Downes CP
Biochem J; 2000 Oct; 351(Pt 1):173-82. PubMed ID: 10998360
[TBL] [Abstract][Full Text] [Related]
20. Nuclear localization of phosphatidylinositol 4-kinase beta.
de Graaf P; Klapisz EE; Schulz TK; Cremers AF; Verkleij AJ; van Bergen en Henegouwen PM
J Cell Sci; 2002 Apr; 115(Pt 8):1769-75. PubMed ID: 11950893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
